ARTICLE | Clinical News
InductOs rhBMP-2/ACS recombinant protein treatment regulatory update
September 23, 2002 7:00 AM UTC
Europe granted marketing approval to the companies' InductOs rhBMP-2/ACS to treat acute tibia fractures in adults, and as an adjunct to open fracture reduction and intramedullary nail fixation. The co...